Search results
Pfizer Inc. (NYSE:PFE) Shares Sold by Waddell & Associates LLC
ETF DAILY NEWS· 7 days agoWaddell & Associates LLC reduced its position in Pfizer Inc. (NYSE:PFE – Free Report) by 40.0% in the 4th quarter, according to its most recent disclosure with the Securities ...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 1 day agoA handful of terrific healthcare stocks have fallen more than 25% from the peaks they set less than...
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
FierceBiotech· 5 days agoPfizer and Flagship Pioneering have settled on the first target for their billion-dollar,...
Bridgeway Capital Management LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoBridgeway Capital Management LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.0% during the 4th quarter, according to its most recent 13F filing ...
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 4 days agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 3 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Pfizer's DMD gene therapy falls short in phase 3 trial
Becker’s Hospital Review· 4 days agoPfizer's gene therapy candidate for Duchenne muscular dystrophy failed to meet its primary endpoint in a phase 3 trial, the company said June 12. The study tested the experimental ...
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open
Barrons.com· 4 days agoThe drug company Pfizer said a gene therapy it is testing failed to improve motor function in boys...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters· 4 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...